These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29192759)

  • 21. Effects of Newly Synthesized Recombinant Human Amyloid-β Complexes and Poly-Amyloid-β Fibers on Cell Apoptosis and Cognitive Decline.
    Park S; Huh JW; Eom T; Na N; Lee Y; Kim JS; Kim SU; Shim I; Lee SR; Kim E
    J Microbiol Biotechnol; 2017 Nov; 27(11):2044-2051. PubMed ID: 28910862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gold-nanoparticle-based multifunctional amyloid-β inhibitor against Alzheimer's disease.
    Gao N; Sun H; Dong K; Ren J; Qu X
    Chemistry; 2015 Jan; 21(2):829-35. PubMed ID: 25376633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oleocanthal enhances amyloid-β clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model.
    Qosa H; Batarseh YS; Mohyeldin MM; El Sayed KA; Keller JN; Kaddoumi A
    ACS Chem Neurosci; 2015 Nov; 6(11):1849-59. PubMed ID: 26348065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.
    Izzo NJ; Staniszewski A; To L; Fa M; Teich AF; Saeed F; Wostein H; Walko T; Vaswani A; Wardius M; Syed Z; Ravenscroft J; Mozzoni K; Silky C; Rehak C; Yurko R; Finn P; Look G; Rishton G; Safferstein H; Miller M; Johanson C; Stopa E; Windisch M; Hutter-Paier B; Shamloo M; Arancio O; LeVine H; Catalano SM
    PLoS One; 2014; 9(11):e111898. PubMed ID: 25390368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis.
    Dedeoglu A; Cormier K; Payton S; Tseitlin KA; Kremsky JN; Lai L; Li X; Moir RD; Tanzi RE; Bush AI; Kowall NW; Rogers JT; Huang X
    Exp Gerontol; 2004; 39(11-12):1641-9. PubMed ID: 15582280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide.
    Gregori M; Taylor M; Salvati E; Re F; Mancini S; Balducci C; Forloni G; Zambelli V; Sesana S; Michael M; Michail C; Tinker-Mill C; Kolosov O; Sherer M; Harris S; Fullwood NJ; Masserini M; Allsop D
    Nanomedicine; 2017 Feb; 13(2):723-732. PubMed ID: 27769888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functionalized Cerium Dioxide Nanoparticles with Antioxidative Neuroprotection for Alzheimer's Disease.
    Hu Y; Guo H; Cheng S; Sun J; Du J; Liu X; Xiong Y; Chen L; Liu C; Wu C; Tian H
    Int J Nanomedicine; 2023; 18():6797-6812. PubMed ID: 38026525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD).
    Nakajima A; Aoyama Y; Shin EJ; Nam Y; Kim HC; Nagai T; Yokosuka A; Mimaki Y; Yokoi T; Ohizumi Y; Yamada K
    Behav Brain Res; 2015 Aug; 289():69-77. PubMed ID: 25913833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice.
    Neumann U; Rueeger H; Machauer R; Veenstra SJ; Lueoend RM; Tintelnot-Blomley M; Laue G; Beltz K; Vogg B; Schmid P; Frieauff W; Shimshek DR; Staufenbiel M; Jacobson LH
    Mol Neurodegener; 2015 Sep; 10():44. PubMed ID: 26336937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
    J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.
    Sánchez-López E; Ettcheto M; Egea MA; Espina M; Cano A; Calpena AC; Camins A; Carmona N; Silva AM; Souto EB; García ML
    J Nanobiotechnology; 2018 Mar; 16(1):32. PubMed ID: 29587747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease.
    Mancini S; Minniti S; Gregori M; Sancini G; Cagnotto A; Couraud PO; Ordóñez-Gutiérrez L; Wandosell F; Salmona M; Re F
    Nanomedicine; 2016 Jan; 12(1):43-52. PubMed ID: 26410276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oligonol improves memory and cognition under an amyloid β(25-35)-induced Alzheimer's mouse model.
    Choi YY; Maeda T; Fujii H; Yokozawa T; Kim HY; Cho EJ; Shibamoto T
    Nutr Res; 2014 Jul; 34(7):595-603. PubMed ID: 25150118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Porphyrinic Metal-Organic Framework PCN-224 Nanoparticles for Near-Infrared-Induced Attenuation of Aggregation and Neurotoxicity of Alzheimer's Amyloid-β Peptide.
    Wang J; Fan Y; Tan Y; Zhao X; Zhang Y; Cheng C; Yang M
    ACS Appl Mater Interfaces; 2018 Oct; 10(43):36615-36621. PubMed ID: 30338980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel monoclonal antibody against the N-terminus of Aβ1-42 reduces plaques and improves cognition in a mouse model of Alzheimer's disease.
    Xing HY; Li B; Peng D; Wang CY; Wang GY; Li P; Le YY; Wang JM; Ye G; Chen JH
    PLoS One; 2017; 12(6):e0180076. PubMed ID: 28662102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery.
    Vilella A; Belletti D; Sauer AK; Hagmeyer S; Sarowar T; Masoni M; Stasiak N; Mulvihill JJE; Ruozi B; Forni F; Vandelli MA; Tosi G; Zoli M; Grabrucker AM
    J Trace Elem Med Biol; 2018 Sep; 49():210-221. PubMed ID: 29325805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
    Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metal-Organic Frameworks Harness Cu Chelating and Photooxidation Against Amyloid β Aggregation in Vivo.
    Yu D; Guan Y; Bai F; Du Z; Gao N; Ren J; Qu X
    Chemistry; 2019 Mar; 25(14):3489-3495. PubMed ID: 30601592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates.
    Barbara R; Belletti D; Pederzoli F; Masoni M; Keller J; Ballestrazzi A; Vandelli MA; Tosi G; Grabrucker AM
    Int J Pharm; 2017 Jun; 526(1-2):413-424. PubMed ID: 28495580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
    Shackleton B; Crawford F; Bachmeier C
    Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.